BIIB

BIIB: To Present At Thomas Weisel Healthcare Conference @ 09:45 ET [delayed] - 09/05 - 08:24 AM ET

Biogen Idec to Present at the 3rd Annual CITI Biotech Day - 09/04 - 01:48 PM ET

Biogen Idec Inc. Is Up Slightly After The Close - 09/02 - 05:32 PM ET

Enrollment Complete in 15-Year Long-Term Follow-Up Study Evaluating Impact of AVONEX(R) in Patients with Relapsing Multiple Sclerosis - 08/27 - 04:18 PM ET

Biogen Idec to Present at the Thomas Weisel Partners Healthcare Conference - 08/26 - 02:43 PM ET

Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy - 08/12 - 05:00 PM ET

Research and Markets: An In-depth Insight into the Partnering Interests and Activites of Biogen Idec Partnering,2008 - 08/11 - 10:52 AM ET

Research and Markets: An In-depth Insight Into the Partnering Interests and Activities of Biogen Idec Partnering, 2008 - 08/11 - 10:51 AM ET

BIIB: To Present At IBC Life Sciences DDT 2008 Conference @ 11:55 ET [delayed] - 08/04 - 10:23 AM ET

BIIB: Conference call regarding For the Investment Community @ 08:30 ET Today [delayed] - 07/31 - 08:26 PM ET

Biogen Idec's Q2 revenues surge - 07/23 - 12:15 PM ET

BIOGEN IDEC SHARES ADD 2.3% TO $68.40 IN PREMARKET - 07/22 - 09:17 AM ET

Biogen Idec 2Q adj eps 91c vs Wall St. estimate 85c - 07/22 - 07:34 AM ET

BIIB: Q2 Earnings Call @ 08:30 ET Today [delayed] - 07/22 - 07:24 AM ET

BIOGEN IDEC SEES 2008 ADJUSTED EPS AT OR ABOVE $3.50 - 07/22 - 07:19 AM ET

BIOGEN IDEC SEES 2008 TOTAL REVENUE GROWTH IN MID-20% RANGE - 07/22 - 07:19 AM ET

BIOGEN IDEC 2Q TR AVG EPS ESTIMATE 85C - 07/22 - 07:18 AM ET

BIOGEN IDEC 2Q REVENUE $993M, UP 28% - 07/22 - 07:18 AM ET

BIOGEN IDEC 2Q AVONEX SALES UP 14% TO $527M, TYSABRI SALES TRIPLED TO $147M - 07/22 - 07:18 AM ET

BIOGEN IDEC 2Q ADJUSTED EPS 91C - 07/22 - 07:17 AM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index